Genetic disorders and congenital malformations in pediatric long-term care

Meghan O'Malley1, R Gordon Hutcheon

  • 1California Pacific Medical Center, San Francisco, CA, USA.

Insights

Genetic disorders and congenital anomalies significantly impact admissions to pediatric long-term care, accounting for half of all admissions. Understanding these conditions is crucial for effective long-term care planning.

Area of Science:

  • Pediatric Long-Term Care
  • Medical Genetics
  • Congenital Malformations

Background:

  • Pediatric long-term care facilities manage a diverse patient population.
  • Understanding the etiological factors behind admissions is essential for resource allocation and care planning.

Purpose of the Study:

  • To determine the proportion of residents in a pediatric long-term care and rehabilitation center with genetic disorders and congenital malformations.
  • To inform administrators about the prevalence of these conditions for future planning.

Main Methods:

  • A retrospective record review was conducted at a 136-bed pediatric long-term care and rehabilitation center in New York City.
  • Resident diagnoses were categorized based on genetic basis, congenital anomalies, and other etiologies over a one-year period.

Main Results:

  • Genetic disorders and/or congenital malformations were identified as the primary reason for 50% of all admissions.
  • These conditions accounted for 60% of admissions requiring end-of-life care.

Conclusions:

  • Genetic disorders and congenital malformations represent a substantial proportion of admissions to pediatric long-term care.
  • This data is vital for long-term care administrators to effectively plan for the specialized needs of their resident population.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Mutations01:39

Mutations

Overview